Protein transduction by pseudotyped lentivirus-like nanoparticles

被引:26
作者
Aoki, T. [1 ]
Miyauchi, K. [1 ]
Urano, E. [1 ]
Ichikawa, R. [1 ]
Komano, J. [1 ]
机构
[1] Natl Inst Infect Dis, AIDS Res Ctr, Shinjuku Ku, Tokyo 1628640, Japan
关键词
LENA; BlaM; Gag; protein transduction; lentiviral vector; IMMUNODEFICIENCY-VIRUS TYPE-1; GAG; HIV-1; VECTORS; FUSION; EXPRESSION; DELIVERY; SEQUENCE; DOMAIN;
D O I
10.1038/gt.2011.38
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
A simple, efficient and reproducible method to transduce proteins into mammalian cells has not been established. Here we describe a novel protein transduction method based on a lentiviral vector. We have developed a method to package several thousand foreign protein molecules into a lentivirus-like nanoparticle (LENA) and deliver them into mammalian cells. In this proof-of-concept study, we used beta-lactamase (BlaM) as a reporter molecule. The amino-terminus of BlaM was fused to the myristoylation signal of lyn, which was placed upstream of the amino-terminus of Gag (BlaM-gag-pol). By co-transfection of plasmids encoding BlaM-gag-pol and vesicular stomatitis virus-G (VSV-G) into 293T cells, LENA were produced containing BlaM enzyme molecules as many as Gag per capsid, which has been reported to be similar to 5000 molecules, but lacking the viral genome. Infection of 293T and MT-4 cells by VSV-G-pseudotyped BlaM-containing LENA led to successful transduction of BlaM molecules into the cell cytoplasm, as detected by cleavage of the fluorescent BlaM substrate CCF2-AM. LENA-mediated transient protein transduction does not damage cellular DNA, and the preparation of highly purified protein is not necessary. This technology is potentially useful in various basic and clinical applications. Gene Therapy (2011) 18, 936-941; doi:10.1038/gt.2011.38; published online 31 March 2011
引用
收藏
页码:936 / 941
页数:6
相关论文
共 22 条
[1]   Improvement of lentiviral vector-mediated gene transduction by genetic engineering of the structural protein Pr55Gag [J].
Aoki, T. ;
Shimizu, S. ;
Urano, E. ;
Futahashi, Y. ;
Hamatake, M. ;
Tamamura, H. ;
Terashima, K. ;
Murakami, T. ;
Yamamoto, N. ;
Komano, J. .
GENE THERAPY, 2010, 17 (09) :1124-1133
[2]   The stoichiometry of Gag protein in HIV-1 [J].
Briggs, JAG ;
Simon, MN ;
Gross, I ;
Kräusslich, HG ;
Fuller, SD ;
Vogt, VM ;
Johnson, MC .
NATURE STRUCTURAL & MOLECULAR BIOLOGY, 2004, 11 (07) :672-675
[3]   Realization of β-lactamase as a versatile fluorogenic reporter [J].
Campbell, RE .
TRENDS IN BIOTECHNOLOGY, 2004, 22 (05) :208-211
[4]   A sensitive and specific enzyme-based assay detecting HIV-1 virion fusion in primary T lymphocytes [J].
Cavrois, M ;
de Noronha, C ;
Greene, WC .
NATURE BIOTECHNOLOGY, 2002, 20 (11) :1151-1154
[5]   Gene delivery by lentivirus vectors [J].
Cockrell, Adam S. ;
Kafri, Tal .
MOLECULAR BIOTECHNOLOGY, 2007, 36 (03) :184-204
[6]   Protein transduction: an alternative to genetic intervention? [J].
Ford, KG ;
Souberbiele, BE ;
Darling, D ;
Farzaneh, F .
GENE THERAPY, 2001, 8 (01) :1-4
[7]   Sequence of human immunodeficiency virus type 1 (HIV-1) gag localization and oligomerization monitored with live Confocal Imaging of a replication-competent, fluorescently tagged EIV-1 [J].
Huebner, Wolfgang ;
Chen, Ping ;
Del Portillo, Armando ;
Liu, Yuxin ;
Gordon, Ronald E. ;
Chen, Benjamin K. .
JOURNAL OF VIROLOGY, 2007, 81 (22) :12596-12607
[8]   CHARACTERIZATION OF RIBOSOMAL FRAMESHIFTING IN HIV-1 GAG-POL EXPRESSION [J].
JACKS, T ;
POWER, MD ;
MASIARZ, FR ;
LUCIW, PA ;
BARR, PJ ;
VARMUS, HE .
NATURE, 1988, 331 (6153) :280-283
[9]  
Klein KC, 2007, AIDS REV, V9, P150
[10]   Inhibiting the Arp2/3 complex limits infection of both intracellular mature vaccinia virus and primate lentiviruses [J].
Komano, J ;
Miyauchi, K ;
Matsuda, Z ;
Yamamoto, N .
MOLECULAR BIOLOGY OF THE CELL, 2004, 15 (12) :5197-5207